Technology
Unisys Announces 2Q24 Results
Published
2 years agoon
By
Unisys Continues Strong Momentum in New Business(6) Signings and Reiterates Full-Year Guidance
Revenue growth of 0.3% year over year (YoY), a 0.5% increase in constant currency(1); Excluding License and Support (Ex-L&S)(15) revenue was flat YoY, a 0.1% increase in constant currencyGross profit margin of 27.2%, an improvement of 290 bps YoY; Ex-L&S gross profit margin of 18.7%, an increase of 270 bps YoYOperating profit margin of 4.9 %; non-GAAP operating profit(8) margin of 6.1 %New Business Total Contract Value (TCV)(4) increased 64% YoY and 17% quarter-over-quarter (QoQ) driven by more than doubling of new logo signings in both YoY and QoQ
BLUE BELL, Pa., Aug. 5, 2024 /PRNewswire/ — Unisys Corporation (NYSE: UIS) reported financial results for the second quarter of 2024.
“Unisys had another strong quarter of new logo signings, which more than doubled sequentially for the third consecutive quarter,” said Unisys Chair and CEO Peter A. Altabef. “Overall New Business TCV grew double-digit year-over-year, which we believe signals strong marketplace momentum for our solution portfolio and recognition of the innovation we are bringing to our clients. We are also continuing to advance industry solutions that bring together data, engineering and industry expertise to drive tangible business value.”
Unisys Chief Financial Officer Deb McCann said, “Unisys reported another solid quarter, with slightly stronger than expected Ex-L&S revenue growth. Our second quarter Ex-L&S gross profit margin improvement of 270 bps compared to prior year extends a track record of execution against our plan to improve profitability. Looking ahead for the second half of the year, we anticipate sequential revenue growth and operating profit and cash flow improvement as New Business signings begin to generate revenue and we further benefit from our operating efficiency initiatives.”
Financial Highlights
Please refer to the accompanying financial tables for a reconciliation of the GAAP to non-GAAP measures presented except for financial guidance since such a reconciliation is not practicable without unreasonable effort.
(In millions, except numbers presented as percentages)
2Q24
2Q23
YTD24
YTD23
Revenue
$478.2
$476.8
$966.0
$993.2
YoY revenue growth
0.3 %
(2.7) %
YoY revenue growth in constant currency
0.5 %
(3.5) %
Ex-L&S revenue
$396.1
$396.0
$790.7
$775.5
YoY revenue growth
— %
2.0 %
YoY revenue growth in constant currency
0.1 %
1.5 %
License and Support(14) revenue
$82.1
$80.8
$175.3
$217.7
YoY revenue growth
1.6 %
(19.5) %
YoY revenue growth in constant currency
2.1 %
(21.1) %
Gross profit
$129.9
$115.8
$265.9
$274.8
Gross profit percent
27.2 %
24.3 %
27.5 %
27.7 %
Ex-L&S gross profit
$74.2
$63.4
$145.4
$115.9
Ex-L&S gross profit percent
18.7 %
16.0 %
18.4 %
14.9 %
Operating profit
$23.6
$0.1
$41.3
$50.0
Operating profit percent
4.9 %
— %
4.3 %
5.0 %
Non-GAAP operating profit
$29.3
$16.3
$63.7
$76.4
Non-GAAP operating profit percent
6.1 %
3.4 %
6.6 %
7.7 %
Net loss attributable to Unisys Corporation
($12.0)
($40.0)
($161.5)
($215.4)
Non-GAAP net income (loss) attributable to Unisys Corporation(10)
$11.0
($6.1)
$13.7
$28.6
EBITDA
$35.6
$9.2
($68.6)
($108.6)
Adjusted EBITDA(9)
$58.4
$50.3
$123.7
$148.5
Adjusted EBITDA as a percentage of revenue
12.2 %
10.5 %
12.8 %
15.0 %
Second Quarter 2024 Results
Revenue growth of 0.3% YoY, a 0.5% increase in constant currency. Ex-L&S revenue was flat YoY, a 0.1% increase in constant currency.
Gross profit margin improved 290 bps YoY and Ex-L&S gross profit margin improved 270 bps YoY primarily driven by delivery improvements and an increase in higher-margin solutions in our New Business signings.
Financial Highlights by Segment
(In millions, except numbers presented as percentages)
2Q24
2Q23
YTD24
YTD23
Digital Workplace Solutions (DWS):
Revenue
$132.1
$135.0
$264.4
$266.0
YoY revenue growth
(2.1) %
(0.6) %
YoY revenue growth in constant currency
(2.2) %
(1.1) %
Gross profit
$21.4
$18.4
$40.4
$34.0
Gross profit percent
16.2 %
13.6 %
15.3 %
12.8 %
Cloud, Applications & Infrastructure Solutions (CA&I):
Revenue
$134.3
$132.6
$263.3
$258.6
YoY revenue growth
1.3 %
1.8 %
YoY revenue growth in constant currency
1.3 %
1.8 %
Gross profit
$23.9
$22.4
$45.3
$38.8
Gross profit percent
17.8 %
16.9 %
17.2 %
15.0 %
Enterprise Computing Solutions (ECS):
Revenue
$137.5
$134.6
$284.5
$322.8
YoY revenue growth
2.2 %
(11.9) %
YoY revenue growth in constant currency
2.5 %
(13.3) %
Gross profit
$76.9
$72.8
$161.9
$198.3
Gross profit percent
55.9 %
54.1 %
56.9 %
61.4 %
Second Quarter 2024 Segment Results
DWS revenue declined 2.1% YoY, a decline of 2.2% in constant currency, but was better than expected at the beginning of the second quarter, as the decline in discretionary volume was more modest than anticipated. DWS gross profit margin was 16.2%, an increase of 260 bps YoY, reflecting results from delivery modernization and efficiency initiatives as well as higher-margin solutions in our New Business signings.
CA&I revenue increased 1.3% in both YoY and constant currency. CA&I gross profit margin was 17.8%, an increase of 90 bps YoY, primarily driven by labor cost savings initiatives.
ECS revenue increased 2.2% YoY, an increase of 2.5% in constant currency. ECS gross profit margin was 55.9%, an increase of 180 bps YoY. The increase in revenue and gross profit margin was primarily driven by the timing of software license renewals and managed services growth.
Balance Sheet and Cash Flows
(In millions)
June 30, 2024
December 31,
2023
Cash and cash equivalents
$ 344.9
$ 387.7
(In millions)
2Q24
2Q23
YTD24
YTD23
Cash provided by operations
$2.7
$42.5
$26.5
$55.3
Free cash flow(11)
($18.5)
$24.7
($14.6)
$17.2
Pre-pension and postretirement free cash flow(12)
($13.8)
$39.4
($2.2)
$48.3
Adjusted free cash flow(13)
($8.0)
$68.1
$9.3
$88.2
Free cash flow declined by ($43.2) million YoY in the second quarter of 2024 and by ($31.8) million in the six months ended June 30, 2024, primarily due to the timing of collections and other fluctuations in working capital.
Other Key Performance Metrics
YoY
Change
QoQ
Change*
TCV
Total company
19 %
25 %
Ex-L&S TCV
10 %
35 %
Pipeline(3)
Total company
(25) %
(7) %
Ex-L&S pipeline
(25) %
(8) %
*
QoQ – quarter over quarter
TCV improvements reported above were primarily impacted by increased New Business TCV of 64% YoY and 17% QoQ, primarily driven by new logo signings more than doubling YoY and QoQ.
Total company and Ex-L&S pipeline declines YoY resulted from strong New Business conversion and timing of the renewal schedule.
Backlog(2) was $2.79 billion for the second quarter of 2024 compared to $2.69 billion for the second quarter of 2023.
2024 Financial Guidance
The company reiterates full-year 2024 revenue growth and profitability guidance:
Guidance
Revenue growth in constant currency
(1.5)% to 1.5%
Non-GAAP operating profit margin
5.5% to 7.5%
Constant currency revenue guidance implies (1.7)% to 1.3% revenue growth as reported, based on recent exchange rates, and assumes Ex-L&S full-year revenue growth of 1.5% to 5.0% and L&S revenue of approximately $375 million.
Conference Call
Unisys will hold a conference call with the financial community on Tuesday, August 6 at 8 a.m. Eastern Time to discuss the results of the second quarter of 2024.
The live, listen-only webcast, as well as the accompanying presentation materials, can be accessed on the Unisys Investor Website at www.unisys.com/investor. In addition, domestic callers can dial 1-844-695-5518 and international callers can dial 1-412-902-6749 and provide the following conference passcode: Unisys Corporation Call.
A webcast replay will be available on the Unisys Investor Website shortly following the conference call. A replay will also be available by dialing 1-877-344-7529 for domestic callers or 1-412-317-0088 for international callers and entering access code 6869066 from two hours after the end of the call until August 20, 2024.
(1) Constant currency – A significant amount of the company’s revenue is derived from international operations. As a result, the company’s revenue has been and will continue to be affected by changes in the U.S. dollar against major international currencies. The company refers to revenue growth rates in constant currency or on a constant currency basis so that the business results can be viewed without the impact of fluctuations in foreign currency exchange rates to facilitate comparisons of the company’s business performance from one period to another. Constant currency is calculated by retranslating current and prior-period revenue at a consistent exchange rate rather than the actual exchange rates in effect during the respective periods.
(2) Backlog – Represents future revenue associated with contracted work, which has not yet been delivered or performed. Although the company believes this revenue will be recognized, it may, for commercial reasons, allow the orders to be canceled, with or without penalty.
(3) Pipeline – Represents qualified prospective sale opportunities for which bids have been submitted or vetted prospective sales opportunities which are being actively pursued. There is no assurance that pipeline will translate into recorded revenue.
(4) Total Contract Value (TCV) – Represents the estimated revenue related to contracts signed in the period without regard for cancellation terms. New Business TCV represents TCV attributable to expansion and new scope for existing clients and new logo contracts.
(5) Book-to-bill – Represents total contract value booked divided by revenue in a given period.
(6) New Business – Represents expansion and new scope for existing clients and new logo contracts.
(7) Next-Gen Solutions – Includes our Modern Workplace solutions within DWS, Digital Platforms and Applications (DP&A) solutions within CA&I, Specialized Services and Next-Gen Compute (SS&C) solutions within ECS, as well as Micro-Market solutions. The company uses estimated Next-Gen Solutions metrics to provide insight into the company’s progress in shifting the revenue mix towards solutions that are generally higher-growth and higher-margin.
(8) Non-GAAP operating profit – This measure excludes pretax pension and postretirement expense and pretax charges in connection with certain legal matters related to professional services and legal fees, including legal defense costs, associated with certain legal proceedings, and cost-reduction activities and other expenses.
(9) EBITDA & adjusted EBITDA – Earnings before interest, taxes, depreciation and amortization (EBITDA) is calculated by starting with net income (loss) attributable to Unisys Corporation common shareholders and adding or subtracting the following items: net income (loss) attributable to noncontrolling interests, interest expense (net of interest income), provision for (benefit from) income taxes, depreciation and amortization. Adjusted EBITDA further excludes pension and postretirement expense; certain legal matters related to settlements, professional services and legal fees, including legal defense costs, associated with certain legal proceedings; environmental matters related to previously disposed businesses; cost-reduction activities and other expenses, non-cash share-based expense, and other (income) expense adjustments.
(10) Non-GAAP net income (loss) and non-GAAP diluted earnings (loss) per share – These measures excluded pension and postretirement expense and charges or (credits) in connection with certain legal matters related to settlements, professional services and legal fees, including legal defense costs, associated with certain legal proceedings; environmental matters related to previously disposed businesses; cost-reduction activities and other expenses. The tax amounts related to these items for the calculation of non-GAAP diluted earnings (loss) per share include the current and deferred tax expense and benefits recognized under GAAP for these items.
(11) Free cash flow – Represents cash flow from operations less capital expenditures.
(12) Pre-pension and postretirement free cash flow – Represents free cash flow before pension and postretirement contributions.
(13) Adjusted free cash flow – Represents free cash flow less cash used for pension and postretirement funding; certain legal matters related to professional services and legal fees, including legal defense costs, associated with certain legal proceedings; environmental matters related to previously disposed businesses; and cost-reduction activities and other payments.
(14) License and Support (L&S) – Represents software license and related support revenue within the company’s ECS segment.
(15) Excluding License and Support (Ex-L&S) – These measures exclude revenue, gross profit and gross profit margin in connection with software license and support revenue within the company’s ECS segment. The company provides these measures to allow investors to isolate the impact of software license renewals, which tend to be significant and impactful based on timing, and related support services in order to evaluate the company’s business outside of these areas.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Unisys cautions readers that the assumptions forming the basis for forward-looking statements include many factors that are beyond Unisys’ ability to control or estimate precisely, such as estimates of future market conditions, the behavior of other market participants and that TCV is based, in part, on the assumption that each of those contracts will continue for their full contracted term. Words such as “anticipates,” “estimates,” “expects,” “projects,” “may,” “will,” “intends,” “plans,” “believes,” “should” and similar expressions may identify forward-looking statements and such forward-looking statements are made based upon management’s current expectations, assumptions and beliefs as of this date concerning future developments and their potential effect upon Unisys. There can be no assurance that future developments will be in accordance with management’s expectations, assumptions and beliefs or that the effect of future developments on Unisys will be those anticipated by management. Forward-looking statements in this release and the accompanying presentation include, but are not limited to, statements made in Mr. Altabef’s and Ms. McCann’s quotations, any projections or expectations of revenue growth, margin expansion, achievement of operational efficiencies and savings, future growth of our Next-Gen Solutions(7), TCV and New Business TCV, the impact of New Logo signings, the impact of Unisys Logistics Optimization, backlog, pipeline, book-to-bill(5), full-year 2024 revenue growth and profitability guidance, including constant currency revenue, Ex-L&S revenue growth, L&S revenue, non-GAAP operating profit margin, free cash flow generation and the assumptions and other expectations made in connection with our full-year 2024 financial guidance, our pension liability, future economic benefits from net operating losses and statements regarding future economic conditions or performance.
Additional information and factors that could cause actual results to differ materially from Unisys’ expectations are contained in Unisys’ filings with the U.S. Securities and Exchange Commission (SEC), including Unisys’ Annual Reports on Form 10-K and subsequent Quarterly Reports on Form 10-Q, recent Current Reports on Form 8-K, and other SEC filings, which are available at the SEC’s web site, http://www.sec.gov. Information included in this release is representative as of the date of this release only and while Unisys periodically reassesses material trends and uncertainties affecting Unisys’ results of operations and financial condition in connection with its preparation of management’s discussion and analysis of results of operations and financial condition contained in its Quarterly and Annual Reports filed with the SEC, Unisys does not, by including this statement, assume any obligation to review or revise any particular forward-looking statement referenced herein in light of future events.
Non-GAAP Information
This release includes certain non-GAAP financial measures that exclude certain items such as postretirement expense; certain legal and other matters related to professional services and legal fees, including legal defense costs, associated with certain legal proceedings; environmental matters related to previously disposed businesses; and cost-reduction activities and other expenses that the company believes are not indicative of its ongoing operations, as they may be unusual or non-recurring. The inclusion of such items in financial measures can make the company’s profitability and liquidity results difficult to compare to prior periods or anticipated future periods and can distort the visibility of trends associated with the company’s ongoing performance. Management also believes that non-GAAP measures are useful to investors because they provide supplemental information about the company’s financial performance and liquidity, as well as greater transparency into management’s view and assessment of the company’s ongoing operating performance.
Non-GAAP financial measures are often provided and utilized by the company’s management, analysts, and investors to enhance comparability of year-over-year results and to isolate in some instances the impact of software license renewals, which tend to be lumpy, and related support services in order to evaluate the company’s business outside of these areas. These items are uncertain, depend on various factors, and could have a material impact on the company’s GAAP results for the applicable period. These measures should not be relied upon as substitutes for, or considered in isolation from, measures calculated in accordance with U.S. GAAP. A reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP can be found below except for financial guidance and other forward-looking information since such a reconciliation is not practicable without unreasonable efforts as the company is unable to reasonably forecast certain amounts that are necessary for such reconciliation. This information has been provided pursuant to the requirements of SEC Regulation G.
About Unisys
Unisys is a global technology solutions company that powers breakthroughs for the world’s leading organizations. Our solutions – cloud, data and AI, digital workplace, logistics and enterprise computing – help our clients challenge the status quo and unlock their full potential. To learn how we have been helping clients push what’s possible for more than 150 years, visit unisys.com and follow us on LinkedIn.
###
RELEASE NO.: 0805/9954
Unisys and other Unisys products and services mentioned herein, as well as their respective logos, are trademarks or registered trademarks of Unisys Corporation. Any other brand or product referenced herein is acknowledged to be a trademark or registered trademark of its respective holder.
UIS-Q
UNISYS CORPORATION
CONSOLIDATED STATEMENTS OF INCOME (LOSS)
(Unaudited)
(Millions, except per share data)
Three Months Ended
June 30,
Six Months Ended
June 30,
2024
2023
2024
2023
Revenue
Services
$ 416.1
$ 417.0
$ 832.9
$ 820.9
Technology
62.1
59.8
133.1
172.3
478.2
476.8
966.0
993.2
Costs and expenses
Cost of revenue
Services
312.1
323.5
627.0
639.6
Technology
36.2
37.5
73.1
78.8
348.3
361.0
700.1
718.4
Selling, general and administrative
101.4
110.3
213.6
213.2
Research and development
4.9
5.4
11.0
11.6
454.6
476.7
924.7
943.2
Operating income
23.6
0.1
41.3
50.0
Interest expense
7.9
7.5
15.8
15.1
Other (expense), net
(9.4)
(16.7)
(151.5)
(213.6)
Earnings (loss) before income taxes
6.3
(24.1)
(126.0)
(178.7)
Provision for income taxes
18.8
15.4
35.8
35.3
Consolidated net loss
(12.5)
(39.5)
(161.8)
(214.0)
Net (loss) income attributable to noncontrolling interests
(0.5)
0.5
(0.3)
1.4
Net loss attributable to Unisys Corporation
$ (12.0)
$ (40.0)
$ (161.5)
$ (215.4)
Loss per share attributable to Unisys Corporation
Basic
$ (0.17)
$ (0.59)
$ (2.34)
$ (3.16)
Diluted
$ (0.17)
$ (0.59)
$ (2.34)
$ (3.16)
UNISYS CORPORATION
SEGMENT RESULTS
(Unaudited)
(Millions)
Total
DWS
CA&I
ECS
Other
Three Months Ended June 30, 2024
Revenue
$ 478.2
$ 132.1
$ 134.3
$ 137.5
$ 74.3
Gross profit percent
27.2 %
16.2 %
17.8 %
55.9 %
Three Months Ended June 30, 2023
Revenue
$ 476.8
$ 135.0
$ 132.6
$ 134.6
$ 74.6
Gross profit percent
24.3 %
13.6 %
16.9 %
54.1 %
Total
DWS
CA&I
ECS
Other
Six Months Ended June 30, 2024
Revenue
$ 966.0
$ 264.4
$ 263.3
$ 284.5
$ 153.8
Gross profit percent
27.5 %
15.3 %
17.2 %
56.9 %
Six Months Ended June 30, 2023
Revenue
$ 993.2
$ 266.0
$ 258.6
$ 322.8
$ 145.8
Gross profit percent
27.7 %
12.8 %
15.0 %
61.4 %
UNISYS CORPORATION
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Millions)
June 30, 2024
December 31,
2023
Assets
Current assets:
Cash and cash equivalents
$ 344.9
$ 387.7
Accounts receivable, net
432.6
454.5
Contract assets
17.4
11.7
Inventories
16.5
15.3
Prepaid expenses and other current assets
96.5
101.8
Total current assets
907.9
971.0
Properties
395.1
396.4
Less-accumulated depreciation and amortization
334.9
332.1
Properties, net
60.2
64.3
Outsourcing assets, net
26.1
31.6
Marketable software, net
169.6
166.2
Operating lease right-of-use assets
38.3
35.4
Prepaid postretirement assets
41.6
38.0
Deferred income taxes
108.9
114.0
Goodwill
287.2
287.4
Intangible assets, net
38.1
42.7
Restricted cash
7.8
9.0
Assets held-for-sale
4.9
4.9
Other long-term assets
177.2
200.9
Total assets
$ 1,867.8
$ 1,965.4
Total liabilities and deficit
Current liabilities:
Current maturities of long-term debt
$ 7.2
$ 13.0
Accounts payable
150.2
130.9
Deferred revenue
190.4
198.6
Other accrued liabilities
244.4
308.4
Total current liabilities
592.2
650.9
Long-term debt
489.2
491.2
Long-term postretirement liabilities
772.3
787.7
Long-term deferred revenue
103.7
104.4
Long-term operating lease liabilities
29.7
25.6
Other long-term liabilities
41.3
44.0
Commitments and contingencies
Total Unisys Corporation stockholders’ deficit
(174.1)
(151.8)
Noncontrolling interests
13.5
13.4
Total deficit
(160.6)
(138.4)
Total liabilities and deficit
$ 1,867.8
$ 1,965.4
UNISYS CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Millions)
Six Months Ended
June 30,
2024
2023
Cash flows from operating activities
Consolidated net loss
$ (161.8)
$ (214.0)
Adjustments to reconcile consolidated net loss to net cash provided by operating activities:
Foreign currency losses (gains)
12.6
(0.5)
Non-cash interest expense
0.6
0.6
Employee stock compensation
11.4
8.9
Depreciation and amortization of properties
12.1
13.7
Depreciation and amortization of outsourcing assets
12.6
25.1
Amortization of marketable software
24.2
24.5
Amortization of intangible assets
4.6
4.9
Other non-cash operating activities
(1.0)
0.4
Loss on disposal of capital assets
—
0.1
Pension and postretirement contributions
(12.4)
(31.1)
Pension and postretirement expense
159.0
203.8
Deferred income taxes, net
0.1
9.3
Changes in operating assets and liabilities, excluding the effect of acquisitions:
Receivables, net and contract assets
31.9
71.0
Inventories
(1.7)
(5.7)
Other assets
(13.4)
(16.1)
Accounts payable and current liabilities
(59.4)
(37.6)
Other liabilities
7.1
(2.0)
Net cash provided by operating activities
26.5
55.3
Cash flows from investing activities
Proceeds from foreign exchange forward contracts
1,519.2
1,485.4
Purchases of foreign exchange forward contracts
(1,524.8)
(1,470.4)
Investment in marketable software
(25.7)
(21.3)
Capital additions of properties
(7.3)
(11.9)
Capital additions of outsourcing assets
(8.1)
(4.9)
Other
(0.1)
(0.4)
Net cash used for investing activities
(46.8)
(23.5)
Cash flows from financing activities
Payments of long-term debt
(10.1)
(10.6)
Other
(1.8)
(0.4)
Net cash used for financing activities
(11.9)
(11.0)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(11.8)
8.7
(Decrease) increase in cash, cash equivalents and restricted cash
(44.0)
29.5
Cash, cash equivalents and restricted cash, beginning of period
396.7
402.7
Cash, cash equivalents and restricted cash, end of period
$ 352.7
$ 432.2
UNISYS CORPORATION
RECONCILIATIONS OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES
(Unaudited)
(Millions, except per share data)
Three Months Ended
Six Months Ended
June 30,
June 30,
2024
2023
2024
2023
Net loss attributable to Unisys Corporation
$ (12.0)
$ (40.0)
$ (161.5)
$ (215.4)
Pension and postretirement expense
pretax
12.4
10.6
159.0
203.8
tax
0.1
(0.2)
0.2
(0.4)
net of tax
12.3
10.8
158.8
204.2
Certain legal matters
pretax
6.5
8.7
(1.7)
14.4
tax
—
—
(2.8)
—
net of tax
6.5
8.7
1.1
14.4
Environmental matters
pretax
0.7
7.5
1.0
17.8
tax
—
—
—
—
net of tax
0.7
7.5
1.0
17.8
Cost reduction and other expenses
pretax
3.5
7.2
14.6
7.9
tax
—
0.3
0.3
0.3
net of tax
3.5
6.9
14.3
7.6
Non-GAAP net income (loss) attributable to Unisys Corporation
$ 11.0
$ (6.1)
$ 13.7
$ 28.6
Weighted average shares (thousands)
69,275
68,289
68,990
68,116
Plus incremental shares from assumed vesting:
Employee stock plans
1,636
—
1,952
646
Non-GAAP adjusted weighted average shares
70,911
68,289
70,942
68,762
Diluted loss per share
Net loss attributable to Unisys Corporation
$ (12.0)
$ (40.0)
$ (161.5)
$ (215.4)
Divided by weighted average shares
69,275
68,289
68,990
68,116
Diluted loss per share
$ (0.17)
$ (0.59)
$ (2.34)
$ (3.16)
Non-GAAP basis
Non-GAAP net income (loss) attributable to Unisys Corporation for
diluted earnings (loss) per share
$ 11.0
$ (6.1)
$ 13.7
$ 28.6
Divided by Non-GAAP adjusted weighted average shares
70,911
68,289
70,942
68,762
Non-GAAP diluted earnings (loss) per share
$ 0.16
$ (0.09)
$ 0.19
$ 0.42
UNISYS CORPORATION
RECONCILIATIONS OF GAAP TO NON-GAAP
(Unaudited)
(Millions)
FREE CASH FLOW
Three Months Ended
Six Months Ended
June 30,
June 30,
2024
2023
2024
2023
Cash provided by operations
$ 2.7
$ 42.5
$ 26.5
$ 55.3
Additions to marketable software
(12.5)
(11.0)
(25.7)
(21.3)
Additions to properties
(5.1)
(4.6)
(7.3)
(11.9)
Additions to outsourcing assets
(3.6)
(2.2)
(8.1)
(4.9)
Free cash flow
(18.5)
24.7
(14.6)
17.2
Pension and postretirement funding
4.7
14.7
12.4
31.1
Pre-pension and postretirement free cash flow
(13.8)
39.4
(2.2)
48.3
Certain legal payments
1.2
10.9
2.6
13.0
Environmental matters payments
2.0
5.0
4.4
10.8
Cost reduction and other payments, net
2.6
12.8
4.5
16.1
Adjusted free cash flow
$ (8.0)
$ 68.1
$ 9.3
$ 88.2
UNISYS CORPORATION
RECONCILIATIONS OF GAAP TO NON-GAAP
(Unaudited)
(Millions)
EBITDA
Three Months Ended
Six Months Ended
June 30,
June 30,
2024
2023
2024
2023
Net loss attributable to Unisys Corporation
$ (12.0)
$ (40.0)
$ (161.5)
$ (215.4)
Net (loss) income attributable to noncontrolling interests
(0.5)
0.5
(0.3)
1.4
Interest expense, net of interest income of $5.3, $6.5, $11.9 and $13.2,
respectively(1)
2.6
1.0
3.9
1.9
Provision for income taxes
18.8
15.4
35.8
35.3
Depreciation
12.3
17.4
24.7
38.8
Amortization
14.4
14.9
28.8
29.4
EBITDA
$ 35.6
$ 9.2
$ (68.6)
$ (108.6)
Pension and postretirement expense
$ 12.4
$ 10.6
$ 159.0
$ 203.8
Certain legal matters(2)
6.5
8.7
(1.7)
14.4
Environmental matters(1)
0.7
7.5
1.0
17.8
Cost reduction and other expenses(3)
1.3
4.8
10.0
3.1
Non-cash share based expense
4.6
4.1
11.1
8.7
Other (income) expense, net adjustment(4)
(2.7)
5.4
12.9
9.3
Adjusted EBITDA
$ 58.4
$ 50.3
$ 123.7
$ 148.5
(1) Included in other (expense), net on the consolidated statements of income (loss).
(2) Included in selling, general and administrative expenses and other (expense), net within the consolidated statements of income (loss). For the six months ended June 30, 2024, certain legal matters includes a net gain of $14.9 million related to a favorable judgement received in a Brazilian services tax matter.
(3) Reduced for depreciation and amortization included above.
(4) Other expense, net as reported on the consolidated statements of income (loss) less pension and postretirement expense, interest income and items included in certain legal and environmental matters, cost reduction and other expenses.
Three Months Ended
Six Months Ended
June 30,
June 30,
2024
2023
2024
2023
Revenue
$ 478.2
$ 476.8
$ 966.0
$ 993.2
Net loss attributable to Unisys Corporation as a percentage of revenue
(2.5) %
(8.4) %
(16.7) %
(21.7) %
Non-GAAP net income (loss) attributable to Unisys Corporation as a
percentage of revenue
2.3 %
(1.3) %
1.4 %
2.9 %
Adjusted EBITDA as a percentage of revenue
12.2 %
10.5 %
12.8 %
15.0 %
UNISYS CORPORATION
RECONCILIATIONS OF GAAP TO NON-GAAP
(Unaudited)
(Millions)
OPERATING PROFIT
Three Months Ended
Six Months Ended
June 30,
June 30,
2024
2023
2024
2023
Operating profit
$ 23.6
$ 0.1
$ 41.3
$ 50.0
Certain legal matters(1)
3.1
8.7
10.4
14.4
Cost reduction and other expenses(2)
2.3
7.1
11.3
11.3
Pension and postretirement expense(1)
0.3
0.4
0.7
0.7
Non-GAAP operating profit
$ 29.3
$ 16.3
$ 63.7
$ 76.4
Revenue
$ 478.2
$ 476.8
$ 966.0
$ 993.2
Operating profit percent
4.9 %
— %
4.3 %
5.0 %
Non-GAAP operating profit percent
6.1 %
3.4 %
6.6 %
7.7 %
(1) Included in selling, general and administrative on the consolidated statements of income (loss).
(2) Included in cost of revenue, selling, general and administrative and research and development on the consolidated statements of income (loss).
EXCLUDING LICENSE AND SUPPORT (EX-L&S) REVENUE AND GROSS PROFIT
Three Months Ended
Six Months Ended
June 30,
June 30,
2024
2023
2024
2023
Revenue
$ 478.2
$ 476.8
$ 966.0
$ 993.2
L&S revenue
82.1
80.8
175.3
217.7
Ex-L&S Non-GAAP revenue
$ 396.1
$ 396.0
$ 790.7
$ 775.5
Gross profit
$ 129.9
$ 115.8
$ 265.9
$ 274.8
L&S gross profit
55.7
52.4
120.5
158.9
Ex-L&S Non-GAAP gross profit
$ 74.2
$ 63.4
$ 145.4
$ 115.9
Gross profit percent
27.2 %
24.3 %
27.5 %
27.7 %
Ex-L&S Non-GAAP gross profit percent
18.7 %
16.0 %
18.4 %
14.9 %
View original content to download multimedia:https://www.prnewswire.com/news-releases/unisys-announces-2q24-results-302214731.html
SOURCE Unisys Corporation
You may like
Technology
Topaz Labs announces its largest single release of AI models in company history with “Next-Gen” launch
Published
16 minutes agoon
April 28, 2026By
DALLAS, April 28, 2026 /PRNewswire/ — Topaz Labs, the AI image and video enhancement company, has announced four new image enhancement models and two video enhancement models across five applications. The collection of “Next-Gen” models offer powerful sharpening, denoising, and upscaling results to visual content. Image models included are Wonder 3, Denoise Max, Super Focus 3, and High Fidelity 3. For video, Starlight Precise 2.5 and Astra 2 were announced.
“This is both the largest and most technically advanced set of models we’ve released in the company’s history,” says Eric Yang, CEO, Topaz Labs. “We launched Topaz NeuroStream earlier this year with the goal of enabling local rendering of complex models for more users. Without such technology, the complex, heavyweight AI models in today’s release would have been limited to cloud-only rendering, forcing users to pay per use and be reliant on internet connection. We believe local use is crucial to the future of AI in both professional and consumer use cases, and today’s release is a huge step.”
Topaz NeuroStream is proprietary technology that reduces VRAM usage by up to 95% and allows exponentially more users on consumer-grade hardware to use AI models locally. A total of six Topaz models are now powered by NeuroStream.
Next-Gen Release Image Models
Wonder 3: A magical, one-click sharpen, upscale, and denoise model for images.
Denoise Max: New standard for removing noise and grain in images.
Super Focus 3: Next-level sharpening model that brings subjects back from the blur.
High Fidelity 3: The newest model for upscaling high-res inputs like smartphone photos and RAW images.
All image models in this release are available in Topaz Photo desktop application and via API. Wonder 3 and Denoise Max are also available in Express, a web-based tool.
Next-Gen Release Video Models
Starlight Precise 2.5 (Local): Groundbreaking video model that brings out natural visual details with stunning results, with local availability in Topaz Video
Astra 2: The next generation of creative video upscaling that enhances clarity, richness, and visual complexity of videos by adding new detail.
Both highlighted video models are available via cloud rendering in Astra and API. Starlight Precise 2.5 (Local) can be found in the Topaz Video desktop application.
About Topaz Labs
Founded in 2005, Topaz Labs is a leader in AI-powered image and video enhancement. Its technology is used by 1.5 million customers, including 20 of the world’s top 50 companies. Known for industry-leading products like Topaz Photo, Topaz Video, Topaz Gigapixel, Astra and Bloom, the company continues to invest heavily in research and development, advancing the frontiers of imaging technology in collaboration with academic and industry partners.
View original content to download multimedia:https://www.prnewswire.com/news-releases/topaz-labs-announces-its-largest-single-release-of-ai-models-in-company-history-with-next-gen-launch-302756375.html
SOURCE Topaz Labs
Technology
Dreame Technology Launches the L60 Series, Led by the Flagship L60 Pro Ultra
Published
16 minutes agoon
April 28, 2026By
New lineup brings industry-leading intelligence and full-home automation to a new generation of robot vacuums
SAN FRANCISCO, April 28, 2026 /PRNewswire/ — Dreame Technology, a leader in smart home innovation, today announced the L60 Series, a new lineup of four robot vacuums engineered for the full range of modern home environments. Built on a shared foundation of premium cleaning performance, intelligent navigation, and hands-free automation, the L60 Series is designed to meet the needs of every kind of household, from compact apartments to multi-story homes, and from single-surface layouts to complex mixed-flooring environments.
“The L60 Series represents exactly what Dreame stands for: powerful, intelligent cleaning that adapts to how people actually live,” said Ana Wang, CEO of Dreame Technology North America. “Whether you have a multi-story home, pets, mixed flooring, or low furniture, there’s an L60 built for your needs. Every model in the lineup delivers the core cleaning experience our customers expect from Dreame.”
Meet the L60 Series
The L60 Series is built around four distinct models, each tailored to a different home profile and cleaning priority:
L60 Pro Ultra — The Ultimate All-in-One. The flagship vacuum is purpose-built for large floor plans, multi-surface transitions, and complex terrain. Features the 3.46-inch ProLeap™ System, 35,000Pa Vormax™ Suction, Dual Omni-Scrub Mopping with Hot Water, and an industry-leading 6,400mAh PowerCore™ Battery.L60 Ultra — Precision Whole-Home Coverage. A balanced high-performer built around Dreame’s latest 2026 sensor technology and a 3.23in (82mm) ultra-thin design for precise navigation in low-light spaces and flawless cleaning under low-profile furniture. Includes AI-Enhanced 3D ToF Vision, 35,000Pa Vormax™ Suction, HyperStream™ Detangling DuoBrush 2.0, SmartDirt™ Detection, Pet-Friendly Care 5.0, and Matter, Apple Watch, and Home Screen Shortcut support.L60 Ultra PE (Performance Edition) — The Intelligent Step-Up. An upgraded everyday performer for homes that need an extra boost on hair pickup, with 30,000Pa Vormax™ Suction, the HyperStream™ Detangling DuoBrush, 3DAdapt™ Obstacle Avoidance, and Smart Pathfinder Technology with 220 object type recognition.L60 Ultra FE (Fine Edition) — The Essential Automated Choice. An entry-level powerhouse delivering the core promise of maintenance-free floor care, with 30,000Pa Vormax™ Suction, TriCut Brush 3.0, Dual Flex Arm Technology, and the full PowerDock™ automation experience.
A Shared Foundation of Premium Performance
Every model in the L60 Series shares a core set of capabilities that set a new baseline for modern robot vacuums, including:
212°F (100°C) ThermoHub™ Mop Self-Cleaning for hygienically clean mop pads after every cycle30,000–35,000Pa Vormax™ Suction across the lineup for powerful pickup on every surfaceDual Flex Arm Technology for adaptive side-brush and mop coverage in corners and along edgesMop Lifting for seamless transitions between hard floors and carpetAutomatic Solution Dispensing for consistent cleaning chemistry without manual refillsThe 8-in-1 PowerDock™ base station, which handles auto-empty, mop washing, hot-air drying, and solution management for truly hands-free operation
L60 Pro Ultra: The Flagship Experience, Redefined for Complex Homes
Leading the lineup is the L60 Pro Ultra, featuring select top-tier specifications optimized for large-scale layouts and complex terrains. It pairs the series’ most capable hardware with Dreame’s most advanced intelligence to deliver a seamless, one-stop cleaning experience that effortlessly tackles stubborn stains across expansive and complex home layouts.
At the heart of the Pro Ultra’s navigation advantage is the 3.46-inch ProLeap™ System, the lineup’s most capable obstacle-crossing system, paired with VersaLift Navigation for cleaning under low-clearance furniture. It is equipped with dual-laser 3D structured light, an AI RGB camera, and LED illumination, enabling it to recognize over 280 types of obstacles — for precise, real-time avoidance in any lighting condition.
The Pro Ultra delivers 35,000Pa Vormax™ Suction alongside the HyperStream™ Detangling DuoBrush, together extracting embedded debris, pet hair, and fine particles from every floor type without tangles or jams. Its Dual Omni-Scrub Mopping with Hot Water system pairs rotating mop pads with a Thermal Mop Pad and ThermoHub™ 212°F (100°C) Mop Self-Cleaning, while the AceClean™ DryBoard minimizes residue — eliminating grease, bacteria, and moisture that cold-water systems simply can’t address. An industry-leading 6,400mAh PowerCore™ Battery provides whole-home coverage on a single charge.
The Pro Ultra’s OmniDirt™ Detection Technology identifies high-soil areas and automatically triggers Mop Rewashing and Floor Remopping for a truly thorough result. Pet-Friendly Care 4.0 adds pet-aware detection and navigation, while Upgraded Intelligent Carpet Cleaning optimizes suction and mop behavior for mixed-flooring homes. Direct Voice Control and app control round out the experience for effortless day-to-day use.
Pricing and Availability
The Dreame L60 Series is available now through the Dreame website and Amazon (L60 Pro Ultra, L60 Ultra, L60 Ultra PE, L60 Ultra FE), with launch-offer pricing through the official website. Customers who purchase on dreametech.com receive a free accessory kit with their order.
L60 Pro Ultra — MSRP $1,399.99 | Launch Offer $1,259.99L60 Ultra — MSRP $1,299.99 | Launch Offer $1,169.99L60 Ultra PE — MSRP $1,099.99 | Launch Offer $879.99L60 Ultra FE — MSRP $999.99 | Launch Offer $749.99
For more information about the L60 Series, visit dreametech.com/pages/l60-series-robot-vacuum.
About Dreame Technology
Established in 2017, Dreame Technology is an innovative consumer product company focused on smart home cleaning appliances with the vision to empower lives through technology. Follow us on Facebook, Instagram, TikTok and Twitter. For more information, please visit https://www.dreametech.com/.
View original content to download multimedia:https://www.prnewswire.com/news-releases/dreame-technology-launches-the-l60-series-led-by-the-flagship-l60-pro-ultra-302756382.html
SOURCE Dreame Technology
Technology
Vanda Pharmaceuticals announces the publication of “Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis” in NEJM Evidence
Published
16 minutes agoon
April 28, 2026By
WASHINGTON, April 28, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of the original research article titled “Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis” in New England Journal of Medicine (NEJM) Evidence1.
The findings of this pivotal phase III study are included in the Biologics License Application (BLA) for imsidolimab for the treatment of Generalized Pustular Psoriasis (GPP), submitted to the U.S. Food and Drug Administration (FDA) with a target action date of December 12, 2026.
References
Smieszek, S. et al. Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis. NEJM Evidence 5, (2026).
About Imsidolimab
Imsidolimab is a fully humanized IgG4 monoclonal antibody that inhibits IL-36 receptor signaling and is being developed for GPP, a rare orphan indication. Regulatory and patent exclusivity for imsidolimab is expected to extend into the late 2030s. Vanda holds an exclusive global license for the development and commercialization of imsidolimab from AnaptysBio (Nasdaq: ANAB).
About Vanda Pharmaceuticals
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Various statements in this press release, including, but not limited to statements regarding the anticipated timing of the completion of the FDA’s review of the imsidolimab BLA; Vanda’s plans to seek FDA approval of imsidolimab for the treatment of GPP; and the potential to extend regulatory and patent exclusivity for imsidolimab into the late 2030s, are “forward-looking statements” under the securities laws. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements are based upon current expectations and assumptions that involve risks, changes in circumstances and uncertainties. Important factors that could cause actual results to differ materially from those reflected in Vanda’s forward-looking statements include, among others, the FDA’s ability to complete its review of, and reach a decision with respect to, the imsidolimab BLA by December 12, 2026; Vanda’s ability to obtain FDA approval of imsidolimab for the treatment of GPP; and Vanda’s ability to satisfy the conditions necessary to extend regulatory and patent exclusivity for imsidolimab into the late 2030s. Therefore, no assurance can be given that the results or developments anticipated by Vanda will be realized, or even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Forward-looking statements in this press release should be evaluated together with the various risks and uncertainties that affect Vanda’s business and market, particularly those identified in the “Cautionary Note Regarding Forward-Looking Statements”, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Vanda’s most recent Annual Report on Form 10-K, as updated by Vanda’s subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov.
All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this press release is provided only as of the date of this press release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-the-publication-of-efficacy-and-safety-of-imsidolimab-for-generalized-pustular-psoriasis-in-nejm-evidence-302756392.html
SOURCE Vanda Pharmaceuticals Inc.
Topaz Labs announces its largest single release of AI models in company history with “Next-Gen” launch
Dreame Technology Launches the L60 Series, Led by the Flagship L60 Pro Ultra
Vanda Pharmaceuticals announces the publication of “Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis” in NEJM Evidence
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market4 days ago
Crypto PAC Fellowship halts support of Texas AG for Senate: Report
-
Technology4 days agoLifeWave’s “Code of Creation” Debuts at Sold-Out Beverly Hills Film Festival
-
Coin Market3 days agoBitcoin traders eye $73K next as weekly trend line holds price hostage
-
Technology4 days agoIDrive® e2 Announces New Storage Region in Tokyo, Delivering High-Performance S3-Compatible Cloud Object Storage Optimized for AI and Modern Data Workloads
-
Coin Market4 days ago
Quantum computer breaks 15-bit elliptic curve cryptographic key
-
Coin Market4 days ago
Quantum computer breaks 15-bit elliptic curve cryptographic key
-
Coin Market4 days ago
US authorities freeze $344M in crypto linked to Iran
-
Coin Market3 days ago
US DOJ sentences man to 70 months in prison for role in $263M scam group
